[{"Assets_0_Q1_USD":449782000.0,"CommonStockSharesOutstanding_0_Q1_shares":46656793.0,"EarningsPerShareBasic_1_Q1_USD":-0.16,"EarningsPerShareDiluted_1_Q1_USD":-0.16,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":8360000.0,"NetIncomeLoss_1_Q1_USD":-7246000.0,"StockholdersEquity_0_Q1_USD":327104000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":46514000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":46514000.0,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180510"}]